日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Frontal Brain Injury Reduces Sensitivity to Reward-Predictive Cues and Remodels the Nucleus Accumbens

额叶脑损伤会降低对奖励预测线索的敏感性并重塑伏隔核

期刊:
影响因子:
doi:10.64898/2026.04.17.718474
Chu, Erskine; McCloskey, Jenna E; Eleid, Mia A; Jami, Sathvik; Dorinsky, Alexandra G; Arega, Fikir B; Martens, Kris M; Zhao, Fangli; Packer, Jonathan M; Stevens, Patrick; Pietrzak, Maciej; Askwith, Candice C; Godbout, Jonathan P; Vonder Haar, Cole
神经科学
发表日期：2026
文献求助 收藏

Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward

针对年轻慢性阻塞性肺疾病患者和慢性阻塞性肺疾病前期患者的治疗试验：是时候向前迈进了。

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202107-1663SO
Martinez, Fernando J; Agusti, Alvar; Celli, Bartolome R; Han, MeiLan K; Allinson, James P; Bhatt, Surya P; Calverley, Peter; Chotirmall, Sanjay H; Chowdhury, Badrul; Darken, Patrick; Da Silva, Carla A; Donaldson, Gavin; Dorinsky, Paul; Dransfield, Mark; Faner, Rosa; Halpin, David M; Jones, Paul; Krishnan, Jerry A; Locantore, Nicholas; Martinez, Fernando D; Mullerova, Hana; Price, David; Rabe, Klaus F; Reisner, Colin; Singh, Dave; Vestbo, Jørgen; Vogelmeier, Claus F; Wise, Robert A; Tal-Singer, Ruth; Wedzicha, Jadwiga A
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS

布地奈德/格隆溴铵/富马酸福莫特罗二水合物对慢性阻塞性肺疾病急性加重、肺功能、症状和生活质量的益处：基于ETHOS研究数据的后验分析

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S374670
Bafadhel, Mona; Rabe, Klaus F; Martinez, Fernando J; Singh, Dave; Darken, Patrick; Jenkins, Martin; Aurivillius, Magnus; Patel, Mehul; Dorinsky, Paul
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

Predictive modeling of COPD exacerbation rates using baseline risk factors

利用基线风险因素对慢性阻塞性肺疾病急性加重率进行预测建模

期刊:Therapeutic Advances in Respiratory Disease
影响因子:3
doi:10.1177/17534666221107314
Singh, Dave; Hurst, John R; Martinez, Fernando J; Rabe, Klaus F; Bafadhel, Mona; Jenkins, Martin; Salazar, Domingo; Dorinsky, Paul; Darken, Patrick
慢性阻塞性肺疾病
发表日期：2022
文献求助 收藏

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

布地奈德/格隆溴铵/福莫特罗治疗慢性阻塞性肺疾病的ETHOS试验显示全因死亡率降低。一项随机、双盲、多中心、平行组研究

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202006-2618OC
Martinez, Fernando J; Rabe, Klaus F; Ferguson, Gary T; Wedzicha, Jadwiga A; Singh, Dave; Wang, Chen; Rossman, Kimberly; St Rose, Earl; Trivedi, Roopa; Ballal, Shaila; Darken, Patrick; Aurivillius, Magnus; Reisner, Colin; Dorinsky, Paul
慢性阻塞性肺疾病
发表日期：2021
文献求助 收藏

Reply to López-Campos et al. and to Rogliani and Calzetta

回复 López-Campos 等人以及 Rogliani 和 Calzetta

期刊:American Journal of Respiratory and Critical Care Medicine
影响因子:19.4
doi:10.1164/rccm.202012-4484LE
Martinez, Fernando J; Darken, Patrick; Dorinsky, Paul
发表日期：2021
文献求助 收藏

Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts

布地奈德/格隆溴铵/福莫特罗定量吸入剂治疗慢性阻塞性肺疾病患者的疗效：KRONOS 研究的事后分析（排除气道可逆性和嗜酸性粒细胞计数高的患者）

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01773-1
Muro, Shigeo; Sugiura, Hisatoshi; Darken, Patrick; Dorinsky, Paul
细胞生物学
慢性阻塞性肺疾病
粒细胞
发表日期：2021
文献求助 收藏

Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids

功能性呼吸影像学评估布地奈德/格隆溴铵/富马酸福莫特罗和格隆溴铵/富马酸福莫特罗定量吸入器在慢性阻塞性肺疾病患者中的应用：吸入性皮质类固醇的价值

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01772-2
van den Berge, Maarten; De Backer, Jan; Van Holsbeke, Cedric; De Backer, Wilfried; Trivedi, Roopa; Jenkins, Martin; Dorinsky, Paul; Aurivillius, Magnus
慢性阻塞性肺疾病
发表日期：2021
文献求助 收藏

Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts

对以下内容的更正：布地奈德/格隆溴铵/福莫特罗定量吸入剂治疗慢性阻塞性肺疾病患者的疗效：KRONOS 研究的事后分析，排除了气道可逆性和嗜酸性粒细胞计数高的患者

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01803-y
Muro, Shigeo; Sugiura, Hisatoshi; Darken, Patrick; Dorinsky, Paul
细胞生物学
慢性阻塞性肺疾病
粒细胞
发表日期：2021
文献求助 收藏

A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

一项关于布地奈德/格隆溴铵/富马酸福莫特罗定量吸入器治疗中重度至极重度慢性阻塞性肺疾病患者的闪烁显像研究

期刊:Respiratory Research
影响因子:5
doi:10.1186/s12931-021-01813-w
Usmani, Omar; Roche, Nicolas; Wahab, Ezanul; Israel, Samuel; Jenkins, Martin; Trivedi, Roopa; Dorinsky, Paul; Aurivillius, Magnus
慢性阻塞性肺疾病
发表日期：2021
文献求助 收藏